{"id":"https://openalex.org/W2016267869","doi":"https://doi.org/10.1016/0014-2999(95)00401-6","title":"Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist","display_name":"Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist","alternate_titles":[],"publication_year":1995,"publication_date":"1995-10-01","ids":{"openalex":"https://openalex.org/W2016267869","doi":"https://doi.org/10.1016/0014-2999(95)00401-6","mag":"2016267869","pmid":"https://pubmed.ncbi.nlm.nih.gov/8566137"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(95)00401-6","doi":"https://doi.org/10.1016/0014-2999(95)00401-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(95)00401-6","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016267869"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011126050","display_name":"Makoto Mizuno","orcid":"https://orcid.org/0000-0002-2300-1618","observed_orcids":["https://orcid.org/0000-0002-2300-1618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Makoto Mizuno","raw_affiliation_strings":["Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089807816","display_name":"Toshio Sada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshio Sada","raw_affiliation_strings":["Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026324990","display_name":"Masahiro Ikeda","orcid":"https://orcid.org/0000-0003-2539-8812","observed_orcids":["https://orcid.org/0000-0003-2539-8812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahiro Ikeda","raw_affiliation_strings":["Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Norio Fukuda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norio Fukuda","raw_affiliation_strings":["Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masaaki Miyamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masaaki Miyamoto","raw_affiliation_strings":["Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109942610","display_name":"Hiroaki Yanagisawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroaki Yanagisawa","raw_affiliation_strings":["Chemical Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Hiroyuki Koike","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hiroyuki Koike","raw_affiliation_strings":["Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd., 2\u201358, Hiromachi 1-Chome, Shinagawa-ku, Tokyo 140, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":1.52,"has_fulltext":false,"cited_by_count":158,"citation_normalized_percentile":{"value":0.83256036,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"285","issue":"2","first_page":"181","last_page":"188"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.902999997138977},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6909999847412109},{"id":"https://openalex.org/keywords/angiotensin-ii-pressor-response","display_name":"angiotensin II pressor response","score":0.8370000123977661},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.753000020980835},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.8420000076293945},{"id":"https://openalex.org/keywords/aortic-contraction","display_name":"aortic contraction","score":0.5080000162124634},{"id":"https://openalex.org/keywords/adrenal-cortex","display_name":"adrenal cortex","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7350501418113708},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7186194658279419},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.516797661781311},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.48230576515197754},{"id":"https://openalex.org/C2780708007","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin II receptor antagonist","level":5,"score":0.479827880859375},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44319888949394226},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4381566047668457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39546313881874084},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3011578917503357},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23270413279533386}],"mesh":[{"descriptor_ui":"D000068557","descriptor_name":"Olmesartan Medoxomil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000302","descriptor_name":"Adrenal Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000302","descriptor_name":"Adrenal Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000758","descriptor_name":"Anesthesia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008566","descriptor_name":"Membranes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008566","descriptor_name":"Membranes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009119","descriptor_name":"Muscle Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009131","descriptor_name":"Muscle, Smooth, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014662","descriptor_name":"Vasoconstrictor Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(95)00401-6","doi":"https://doi.org/10.1016/0014-2999(95)00401-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(95)00401-6","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8566137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8566137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1543348686","https://openalex.org/W1825266751","https://openalex.org/W1978739653","https://openalex.org/W2017800047","https://openalex.org/W2024608428","https://openalex.org/W2048235565","https://openalex.org/W2055901844","https://openalex.org/W2065561654","https://openalex.org/W2085147947","https://openalex.org/W2110868309","https://openalex.org/W2111316251","https://openalex.org/W2117669993","https://openalex.org/W2119995804","https://openalex.org/W2161243596","https://openalex.org/W2608811105","https://openalex.org/W4285719527","https://openalex.org/W6638633957","https://openalex.org/W6676774024"],"related_works":["https://openalex.org/W2323447142","https://openalex.org/W2314666433","https://openalex.org/W3102451470","https://openalex.org/W2087790961","https://openalex.org/W2030693447","https://openalex.org/W2042630459","https://openalex.org/W2089536407","https://openalex.org/W2022661628","https://openalex.org/W2078531788","https://openalex.org/W2050333165"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016267869","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
